Singapore’s Health Sciences Authority (HSA) has expanded the label of GlaxoSmithKline (GSK)’s Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to ...
GlaxoSmithKline is to sell a portfolio of anaesthetics to South Africa’s Aspen in a deal worth up to £280 million. The companies, which have worked closely together for several years ...
With the approval, GSK adds a key new option to its market-leading meningitis vaccine portfolio. In a phase 3 study, GSK's vaccine—given in two doses six months apart—showed immunological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback